Jiménez Sònia, Cervera Ricard, Font Josep, Ingelmo Miguel
Department of Autoimmune Diseases, Institut Clínic d'Infeccions i Immunologia, Hospital Clínic, Barcelona, Catalonia, Spain.
Clin Rev Allergy Immunol. 2003 Aug;25(1):3-12. doi: 10.1385/CRIAI:25:1:3.
Systemic lupus erythematosus (SLE) is the most diverse of the autoimmune diseases because it may affect any organ of the body and display a broad spectrum of clinical and immunological manifestations. Although previously considered a rare disease, SLE now appears to be relatively common in certain groups of the population. This is probably due to the development of several immunological tests that have allowed the description of many atypical or benign cases that otherwise might not be diagnosed. Furthermore, with the introduction since 1982 of a set of more sensitive criteria for SLE classification, more cases can nowadays be detected. In the present article, we review the most important data regarding the incidence and prevalence of this disease in the general population, the epidemiologic information on the patterns of disease expression in specific subsets and the studies on mortality in SLE. An important amount of information comes from the data obtained from the "Euro-Lupus Cohort," a series of 1000 patients with SLE from several European countries that have been followed prospectively since 1991.
系统性红斑狼疮(SLE)是自身免疫性疾病中最多样化的一种,因为它可能影响身体的任何器官,并表现出广泛的临床和免疫学表现。尽管SLE以前被认为是一种罕见疾病,但现在在某些人群中似乎相对常见。这可能是由于几种免疫学检测方法的发展,这些方法使得许多非典型或良性病例得以描述,否则这些病例可能无法被诊断出来。此外,自1982年以来引入了一套更敏感的SLE分类标准,如今可以检测到更多病例。在本文中,我们回顾了关于该疾病在一般人群中的发病率和患病率的最重要数据、特定亚组中疾病表现模式的流行病学信息以及SLE死亡率的研究。大量信息来自于“欧洲狼疮队列”的数据,该队列包括来自几个欧洲国家的1000例SLE患者,自1991年以来一直进行前瞻性随访。